ARCHIVES

Hagop Kantarjian: Why Drugs Cost Too Much and How Prices Can be Brought Down

This article is from The Cancer Letter archive.

Vol. 39 No. 22 | May 31, 2013

Download PDF Visit The Full Archive

Related Articles

FDA Approves New Toxicology Protocol; Drug Program Under Fire; DCT Board Approves Cutbacks, Contract Concepts

October 9, 1981

Zerhouni Starts Work As NIH Director

May 24, 2002

NCI Oks Expanded Breast Cancer Low Fat Prevention Trial, Plans To End Stage 2 Adjuvant Low Fat Study

January 31, 1986

NCI Faced Pressure From Congress, HHS, White On Mammography Statement

April 11, 1997

IOM To Form Committee To Investigate Duke Genomics Research

October 1, 2010

ACS Picks Up Study Of tobacco Industry Influence On Voting By State Legislators

May 3, 1996